Vertex says “no evidence” of Symdeko-related deaths

In a statement to STAT, Vertex Pharmaceuticals (VRTX +0.1%) says it has no evidence linking cystic fibrosis med Symdeko to the reported deaths on the FDA’s FAERS dashboard and has received no communication from the agency about the drug’s safety.

Shares initially sold off ~4% on the news, but have recovered.

https://seekingalpha.com/news/3495356-vertex-says-evidence-symdeko-related-deaths